Therapeutic Potential for Tetracyclines in the Treatment of COVID-19

Pharmacotherapy. 2020 May;40(5):487-488. doi: 10.1002/phar.2395. Epub 2020 May 4.

Authors

Mohit Sodhi¹, Mahyar Etminan^{1

2

3}

Affiliations

¹ Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
² Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
³ Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

No abstract available

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Betacoronavirus / drug effects
Betacoronavirus / physiology
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy*
Humans
Pandemics
Pneumonia, Viral / drug therapy*
SARS-CoV-2
Tetracyclines / therapeutic use*
Virus Replication / drug effects

Substances

Anti-Inflammatory Agents
Tetracyclines